Patient identification and Site Engagement
Strategic Recruitment and Site Activation for Oncology Trials
Our approach to patient identification and site engagement is designed to accelerate enrollment and ensure your trial reaches the right patients at the right time. Leveraging our oncology specialization, we build targeted strategies that reduce recruitment timelines and enhance site collaboration.
We understand the critical importance of early and consistent patient access in clinical research. That’s why our model integrates real-world data, high-performing sites, and expert outreach to deliver meaningful results.
Optimized Recruitment Through Strategic Site Collaboration
Our clinical team works closely with investigators and coordinators to identify eligible patients quickly and accurately. By understanding the nuances of oncology indications and applying precision targeting methods, we support rapid trial startup and sustained enrollment momentum.
Our patient identification and engagement services include:
- Comprehensive feasibility assessments to select high-performing sites
- Collaboration with investigators to identify patients within their existing databases
- Coordination with referring physicians and local networks to expand outreach
- Tailored patient recruitment plans, including pre-screening and inclusion/exclusion alignment
- Ongoing site support to maintain engagement and performance
Request more information about our Clinical Trial Services
Contact our experts to help advance your drug development with TD2's Comprehensive Oncology Ecosystem.
Oncology Expertise That Drives Enrollment
Because oncology is our sole focus, we speak the same language as your investigators and clinical teams. We understand the barriers that often delay oncology trial enrollment—and we’ve developed proven processes to overcome them. From first contact through final visit, we remain an active partner with your sites to ensure high-quality data and dependable patient participation.
Collaborate with Our Peak Partners
Our Peak Partners program offers an elite network of experienced oncology sites and investigators who have demonstrated consistent performance in clinical research. By working with Peak Partners, you gain access to streamlined site onboarding, accelerated patient referrals, and collaborative trial execution.
Your Oncology Enrollment Partner
TD2 Oncology integrates seamlessly with your broader clinical strategy, acting as an extension of your team to ensure proactive site management and patient engagement from day one. Whether you're navigating rare indications or recruiting in a competitive landscape, we’re equipped to help you enroll smarter and faster. As part of TD2’s comprehensive oncology ecosystem, our patient identification and site engagement services connect directly with preclinical, regulatory, and clinical operations providing continuity, insight, and speed throughout your development journey.
Additional Resources
Clinical, Preclinical, Posters and Publications
Leading the way in defining a new Immunotherapy Response Score (IRS) to predict checkpoint inhibitor benefit
Clinical, White Papers
Early Phase Oncology Trial Designs Phase I Strategies Tailored for Success
Videos
TD2 Clinical Capabilities
